Vanderbilt General Clinical Research Center

September 4, 2019

Novel treatment for Prader-Willi syndrome being tested at VUMC

A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.

By Leigh MacMillan

April 19, 2018

Symposium to honor Robertson’s research contributions

David Robertson, MD, internationally known for his groundbreaking work in defining and treating often-debilitating neurological disorders of blood pressure regulation, will be honored with a two-day symposium May 3-4 at Langford Auditorium.

By Bill Snyder

November 30, 2017

Robertson leaves lasting legacy in clinical research

When David Robertson, MD, sorted through 39 years’ worth of textbooks, journals and framed photographs in Vanderbilt University Medical Center’s (VUMC) Clinical Research Center (CRC) recently as he prepared for retirement, the memory that brought him to tears was a 30-year-old embroidery piece by his daughter, Rose Robertson Pink.

By Nancy Humphrey

November 30, 2017

Niswender named Clinical Research Center director

Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabolic syndrome, has been named director of the Clinical Research Center (CRC) at Vanderbilt University Medical Center (VUMC).

By Bill Snyder

November 6, 2014

Autonomic diseases consortium lands renewed federal funding

A nationwide research group headed by Vanderbilt University’s David Robertson, M.D., has received another round of funding from the federal government to continue studies of rare neurodegenerative diseases and disorders affecting blood pressure.

By Bill Snyder

April 13, 2012

Study examines sleep apnea’s role in lung diseases

Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases.

By Kathy Whitney